Blau Farmacêutica S.A.
São Paulo Stock Exchange BLAU3.SA
Blau Farmacêutica S.A. EBIT Margin for the year ending December 31, 2023: 27.08%
-
Blau Farmacêutica S.A. EBIT Margin for the year ending December 31, 2022 was 35.88%, a -4.37% change year over year.
-
Blau Farmacêutica S.A. EBIT Margin for the year ending December 31, 2021 was 37.52%, a 19.33% change year over year.
-
Blau Farmacêutica S.A. EBIT Margin for the year ending December 31, 2020 was 31.44%, a 1.56% change year over year.
-
Blau Farmacêutica S.A. EBIT Margin for the year ending December 31, 2019 was 30.95%, a 23.20% change year over year.
| Date | EBIT Margin | EPS (Basic) | EPS (Diluted) | Shares (Basic, Weighted) |
|---|
Don’t Miss A Beat
| CEO | Mr. Marcelo Rodolfo Hahn |
| IPO Date | April 19, 2021 |
| Location | Brazil |
| Headquarters | Rodovia Raposo Tavares, 2833, km 30,5 |
| Employees | 1,900 |
| Sector | Healthcare |
| Industries | |
Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood-derived, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Past 5 years
StockViz Staff
February 8, 2025
Any question? Send us an email